摘要:
There is disclosed an osmotic concentration cell wherein the flow chamber of the osmotic concentration cell has a continually changing flow path to provide a region of high turbulence to a semipermeable membrane defining the flow chamber. High turbulence at a first semipermeable membrane interface significantly reduces membrane fouling during osmotic concentration and allows for concentration of products with high suspended solids content. The inventive osmotic concentration cell can be used for a variety of purposes including, for example, producing low alcohol wine, concentrating a thin wine into a premium wine, concentrating a low quality grape juice into a higher quality grape juice for fermenting a more premium wine, concentrating various fruit or vegetable juices, and concentrating various beverages, such as teas or coffee.
摘要:
INSTANT COFFEE IS PRODUCED BY A DUAL EXTRACTION PROCESS IN WHICH THE TWO COFFEE EXTRACTS ARE ULTIMATELY COMBINED TO PROVIDE THE FINAL PRODUCT. IN THE FIRST EXTRACTION WATER AT A TEMPERATURE OF 210*F. IS ADDED TO GROUND COFFEE IN THE RATIO OF 2.5 TO 4.5 PARTS BY WEIGHT OF WATER TO EACH PART OF GROUND COFFEE. THE MIXTURE IS PERMITTED TO REACH EQUILIBRIUM CONDITIONS, RESULTING IN THE PRODUCTION OF A COFFEE EXTRACT HAVING APPORXIMATELY 7% BY WEIGHT OF THE WATER SOLUBLE COMPONENTS OF THE GROUP COFFEE THEREIN. THE REMAINING GROUNDS ARE THEN SUBJECTED TO THE SECOND EXTRACTION PROCESS.
摘要:
Aspects described herein relate to food and beverage compositions infused with lipophilic active agents and methods of use for the treatment of a variety of disorders. More particularly, aspects described herein relate to food and beverage compositions infused with lipophilic active agents such as cannabinoids, nicotine, nonsteroidal anti-inflammatories (NSAIDs), and vitamins, that provide enhanced bioavailability of the lipophilic active agents in a subject, and that mask unpleasant tastes of lipophilic active agents.
摘要:
Aspects described herein relate to food and beverage compositions infused with lipophilic active agents and methods of use for the treatment of a variety of disorders. More particularly, aspects described herein relate to food and beverage compositions infused with lipophilic active agents such as cannabinoids, nicotine, nonsteroidal anti-inflammatories (NSAIDs), and vitamins, that provide enhanced bioavailability of the lipophilic active agents in a subject, and that mask unpleasant tastes of lipophilic active agents.
摘要:
A process for the manufacture of a soluble beverage powder is provided, the process comprising the steps of; (a) forming a mass comprising a beverage concentrate; (b) contacting at least a portion of a surface of the mass with a water permeable membrane, whereby water passes from the mass through the permeable membrane to at least partially dry the mass; and (c) texturising the at least partially dried mass to form the soluble beverage powder, wherein, before step (b), at least a portion of the surface of the mass is coated with a substantially dry edible powder.
摘要:
The present disclosure relates to a process for the production of a liquid coffee concentrate that has an improved storage stability at ambient temperature. The process comprises separating coffee extract resulting in a high aromatic coffee extract and a low aromatic coffee extract and subjecting the low aromatic coffee extract to a heat treatment and, optionally, a pH rising step.
摘要:
The present invention is directed to a technique of producing an ultra-concentrated liquid coffee that is shelf-stable at ambient temperature without the need for refrigeration or freezing. This invention further relates to a process for manufacturing ultra-concentrated stabilized liquid coffee with enhanced freshness, aroma and flavor retention without acidity or bitterness.
摘要:
Provided is a concentrated coffee composition containing chlorogenic acids at a high concentration and having good taste or flavor. The concentrated coffee composition of the present invention contains the following components (A) and (B): 100 to 300 mg/g of chlorogenic acids (A) in dry solids content; and not more than 0.33 mg/g of 5-hydroxymethylfurfural (B) in dry solids content, wherein the dry solids content is 10 to 100 mass %.